J. Eyfjörd

发表

Signatures of mutational processes in human cancer

David T. W. Jones, David C. Jones, M. Meyerson, 2013, Nature.

p53 abnormalities and genomic instability in primary human breast carcinomas.

J. Eyfjörd, S. Thorlacius, M. Steinarsdóttir, 1995, Cancer research.

Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis

J. Eyfjörd, J. Jónasson, M. Steinarsdóttir, 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.

J. Eyfjörd, B. Agnarsson, S. Grétarsdóttir, 1996, British Journal of Cancer.

Combined effect of low-penetrant SNPs on breast cancer risk

J Dillner, J. Eyfjörd, J. Carlson, 2011, British Journal of Cancer.

Study of a single BRCA2 mutation with high carrier frequency in a small population.

J. Eyfjörd, J. Jónasson, S. Thorlacius, 1997, American journal of human genetics.

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

J. Eyfjörd, Olafur A Stefansson, Margrét Aradóttir, 2017, Cancer Epidemiology, Biomarkers & Prevention.

BRCA2 germline mutations in Swedish breast cancer families

J. Eyfjörd, A. Lindblom, B. Arver, 1998, European Journal of Human Genetics.

BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.

J. Eyfjörd, S. Grétarsdóttir, J. Jónasson, 1998, Cancer research.

TP53 abnormalities and genetic instability in breast cancer.

J. Eyfjörd, S. Grétarsdóttir, S. Thorlacius, 1995, Acta oncologica.

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

A. Børresen-Dale, C. Larsson, Å. Borg, 1998, Cancer research.

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Bin Tean Teh, Andrew Menzies, Keiran Raine, 2014, eLife.

p53 abnormality and chromosomal instability in the same breast tumor cells.

J. Eyfjörd, J. Jónasson, M. Steinarsdóttir, 2000, Cancer genetics and cytogenetics.

Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

Å. Borg, J. Eyfjörd, P. Devilee, 1997, Genes, chromosomes & cancer.

Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short‐term culture

J. Eyfjörd, M. Steinarsdóttir, S. Snorradóttir, 1995, Genes, chromosomes & cancer.

Mutagenic DNA repair in escherichia coli. V. Mutation frequency decline and error-free post-replication repair in an excision-proficient strain.

J. Eyfjörd, M. Green, W. Muriel, 1977, Mutation research.

Mutagenic DNA repair in Escherichia coli: conditions for error-free filling of daughter strand gaps.

J. Eyfjörd, M. Green, B. Bridges, 1975, Journal of general microbiology.

Cytogenetic polyclonality of breast carcinomas : Association with Clinico‐Pathological Characteristics and Outcome

J. Eyfjörd, J. Jónasson, M. Steinarsdóttir, 2011, Genes, chromosomes & cancer.

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo

M. Hurles, A. Børresen-Dale, M. Stratton, 2017, Nature.

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

Andrew Menzies, Adam P. Butler, Jon W. Teague, 2014, Science.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2015, Genome research.

MYC amplification and TERT expression in breast tumor progression.

J. Eyfjörd, J. Jónasson, M. Steinarsdóttir, 2007, Cancer genetics and cytogenetics.

Mutations in exons 5–8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma

M. J. van de Vijver, J. Nesland, J. Eyfjörd, 1999, The Journal of pathology.

Tubio retrotransposition in cancer genomes Extensive transduction of nonrepetitive DNA mediated by L 1

M. Stratton, P. Futreal, P. Campbell, 2014 .

Screening for germ line TP53 mutations in breast cancer patients.

S. Friend, E. Hovig, J. Eyfjörd, 1992, Cancer research.

BRCA2 Haploinsufficiency in Telomere Maintenance

J. Eyfjörd, M. Steinarsdóttir, Birna Thorvaldsdottir, 2021, Genes.

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

J. Struewing, J. Eyfjörd, S. Wacholder, 1998, The Lancet.

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

J. Eyfjörd, J. Jónasson, T. Jónsson, 2006, Journal of the National Cancer Institute.

BRCA2 mutation in Icelandic prostate cancer patients

J. Eyfjörd, K. Benediktsdottir, E. Jonsson, 1997, Journal of Molecular Medicine.

Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization.

J. Eyfjörd, M. Steinarsdóttir, H. Ogmundsdottir, 1996, Cancer genetics and cytogenetics.

Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome

J. Eyfjörd, J. Carlson, K. Hemminki, 2011, Breast Cancer Research and Treatment.

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.

J. Eyfjörd, S. Thorlacius, A. L. Börresen, 1993, Cancer research.

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

J. Eyfjörd, S. Thorlacius, J. Eyfjord, 1995, European journal of cancer.

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

E. Hovig, Å. Borg, J. Eyfjörd, 1995, Genes, chromosomes & cancer.

A candidate CpG SNP approach identifies a breast cancer associated ESR1‐SNP

J. Eyfjörd, J. Carlson, K. Hemminki, 2011, International journal of cancer.

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts

H. Tanke, J. Eyfjörd, P. Devilee, 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Corrigendum: Signatures of mutational processes in human cancer

Roland Eils, Natalie Jäger, Adam P. Butler, 2013, Nature.

Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients’ Clinical Outcome

J. Eyfjörd, K. Hemminki, U. Hamann, 2014, PloS one.

Inbreeding and homozygosity in breast cancer survival

J. Eyfjörd, K. Hemminki, U. Hamann, 2015, Scientific Reports.

Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer

J. Eyfjörd, J. Carlson, J. Dillner, 2012, BMC Women's Health.

Centriole movements in mammalian epithelial cells during cytokinesis

H. Tanke, J. Eyfjörd, J. Vrolijk, 2010, BMC Cell Biology.

Molecular genetics and cytogenetics of breast carcinomas: comparison of the two methods.

J. Eyfjörd, M. Steinarsdóttir, R. Valgardsdottir, 1996, Cancer genetics and cytogenetics.

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

J. Eyfjörd, S. Tavtigian, J. Jónasson, 1996, Nature Genetics.

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo

M. Hurles, A. Børresen-Dale, M. Stratton, 2017, Nature.

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2016, Genome research.

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

A. Børresen-Dale, M. Stratton, M. J. van de Vijver, 2014, Science.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

Fengtang Yang, A. Børresen-Dale, M. Stratton, 2015, Genome research.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

A. Børresen-Dale, J. Esteve, C. Desmedt, 2017 .